相关实验视频

Updated: May 13, 2026

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.0K

在血液恶性瘤的CAR T细胞治疗期间急性症状性发作:三站式梅奥诊所经验

Brin E Freund1, Anteneh M Feyissa1, Oluwatoni E Betiku2

  • 1Department of Neurology, Mayo Clinic, Jacksonville, FL.

Neurology
|April 11, 2025
PubMed
概括

化学抗原受体T细胞 (CAR T细胞) 治疗具有急性症状性发作 (ASyS) 的低风险. 风险因素包括细胞毒性释放综合征和较高的免疫效应细胞相关神经毒性综合征 (ICANS) 等级,但ASyS不会最终影响结果.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.2K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.